Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
344 people get GNVC articles and Market Currents by email alert.
Get email alerts on GNVC »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
PR Newswire (Mar 22, 2013)
-
PR Newswire (Mar 12, 2013)
-
PR Newswire (Nov 14, 2012)
-
GenVec's CEO Discusses Q3 2012 Results - Earnings Call TranscriptFri, Nov 9, 2012
-
PR Newswire (Nov 9, 2012)
-
PR Newswire (Nov 2, 2012)
-
PR Newswire (Oct 2, 2012)
-
PR Newswire (Oct 1, 2012)
-
PR Newswire (Sep 25, 2012)
-
GenVec's CEO Discusses Q2 2012 Results - Earnings Call TranscriptThu, Aug 9, 2012
-
PR Newswire (Aug 9, 2012)
-
PR Newswire (Aug 2, 2012)
To learn more about Seeking Alpha Pro, click here.
-
Life Sciences Companies Raise Record Amounts of CapitalThe Burrill Report • Fri, Dec 31, 2010
-
Biotech Deal Activity Takes a BreatherThe Burrill Report • Sun, Apr 4, 2010
-
A Major Setback for GenVecZacks Investment Research • Tue, Mar 30, 2010
-
GenVec's CEO Discusses Q3 2012 Results - Earnings Call TranscriptFri, Nov 9, 2012
-
GenVec's CEO Discusses Q2 2012 Results - Earnings Call TranscriptThu, Aug 9, 2012
-
GenVec, Inc. Q2 2008 Earnings Call TranscriptFri, Aug 8, 2008
-
GenVec, Inc. Q1 2008 Earnings Call TranscriptFri, May 9, 2008
-
GenVec Inc. Q4 2007 Earnings Call TranscriptFri, Mar 14, 2008
-
GenVec Q3 2007 Earnings Call TranscriptWed, Nov 7, 2007
-
PR Newswire (Mar 22, 2013)
-
PR Newswire (Mar 12, 2013)
-
PR Newswire (Nov 14, 2012)
-
PR Newswire (Nov 9, 2012)
-
PR Newswire (Nov 2, 2012)
-
PR Newswire (Oct 2, 2012)
-
PR Newswire (Oct 1, 2012)
-
PR Newswire (Sep 25, 2012)
-
PR Newswire (Aug 9, 2012)
-
PR Newswire (Aug 2, 2012)
-
at MarketWatch.com (Jun 7, 2012)
-
PR Newswire (Jun 7, 2012)
-
PR Newswire (May 25, 2012)
-
PR Newswire (May 21, 2012)
-
PR Newswire (May 10, 2012)
-
GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012PR Newswire (May 3, 2012)
-
PR Newswire (May 3, 2012)
-
PR Newswire (Apr 6, 2012)
GNVC vs. ETF Alternatives
Company Description
GenVec, Inc. (GenVec, we, our, or the Company) is a clinical stage biopharmaceutical company developing novel, gene-based therapeutic drugs and vaccines. Our lead therapeutic product candidate, TNFeradeTM biologic (TNFerade), is being developed for use in the treatment of cancer. TNFerade is... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 13, 2:25 PM GenVec (GNVC -33%) gets slammed today after its FQ4 missed hard on the revenue side. Sales were down 56% year over year, impacted by a decline in revenue from its hearing loss and balance disorders, HIV, and foot and mouth disease programs. Comment! [Healthcare, Earnings, On the Move]
-
Monday, May 13, 12:50 PM
Midday top 10 gainers: PNTR +65%. TGX +36%. SCTY +33%. CNIT +28%. SUTR +20%. UNIS +19%. ALIM +19%. LEDS +19%. NOAH +17%. HTCH +17%.
Midday top 10 losers: GNVC -34%. ATEA -18%. SBLK -18%. RCON -15%. EOX -8%. DRWI -8%. PLG -8%. MRIN -8%. JOSB -7%. CIMT -7%. Comment! [On the Move] -
Thursday, April 11, 12:49 PM
Midday top 10 gainers: ACAD +55%. RNIN +26%. RAD +18%. ZUMZ +15%. MEA +13%. BIOL +12%. MGT +12%. PBTH +12%. MPAC +11%. TVL +11%.
Midday top 10 losers: LEDS -17%. FTNT -14%. ROYL -14%. NTIC -16%. HXM -11%. CREG -11%. PRMW -10%. GNVC -10%. SGYP -10%. OCZ -10%. Comment! [On the Move] - Friday, March 22, 8:12 AM GenVec (GNVC): Q4 EPS of -$0.24 beats by $0.03. Revenue of $1.5M misses by $2.2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, December 17, 2012, 12:45 PM Shares of biopharmaceutical developer GenVec (GNVC +37%) surge after the company reported earlier that a single dose of its genetic vaccine showed it was effective against Herpes Simplex Virus or HSV2 in two industry-accepted HSV disease models. The company added that immunization was also shown to reduce viral shedding and the recurrence and severity of lesions. Comment! [Healthcare, On the Move]
-
Monday, December 17, 2012, 12:45 PM
Midday top 10 gainers: GNVC +37%. CBOU +30%. HRT +16%. CEDC +15%. OCZ +13%. CPWR +13%. ONCY +13%. JVA +12%. VELT +12%. HTCH +12%.
Midday top 10 Losers: SCL -48%. GYRO -31%. END -20%. OPXA -13%. CLWR -12%. XUE -12%. SSE -11%. ALIM -11%. RVM -11%. NBG -9%. 1 Comment [On the Move] - Monday, October 1, 2012, 1:31 PM Shares of biopharmaceutical developer GenVec (GNVC +4.4%) jump after releasing positive data on one of its RSV vaccine programs at a conference over the weekend. The company says data on its vaccine candidate showed it to be highly immunogenic and avoids the problems of vector specific immunity that has hampered other similar vectored vaccines. Comment! [Healthcare, On the Move]
- Thursday, June 7, 2012, 8:33 AM GenVec (GNVC) surging 19% after the USDA's Animal & Plant Health Inspection Service grants a conditional license for GenVec's vaccine for foot-and-mouth disease for use in cattle. GenVec also licenses the rights to develop and commercialize the technology to Sanofi's (SNY) Merial unit. (PR) 2 Comments [On the Move, Healthcare]
- Tuesday, March 30, 2010, 10:39 AM GenVec (GNVC) tumbles 71.9% after it discontinues a trial for its lead gene therapy drug for pancreatic cancer. Interim results showed it was unlikely to become effective. Comment!
-
Friday, March 19, 2010, 9:00 AM
Premarket gainers: LYG +10%. LGF +8%. CRBC +8%. GNVC +4%. RBS +4%. BBY +4%. AIB +4%.
Losers: PALM -17%. SPWRA -10%. SB -7%. GNBT -7%. HT -4%. GSL -4%. 1 Comment -
Monday, March 8, 2010, 9:00 AM
Premarket gainers: XRTX +17%. CTIC +16%. CHGS +11%. SEED +11%. ANO +8%. MSN +8%. CNAM +7%. EBIX +6%. GMO +5%. AIG +4%. RFMD +4%. MET +4%. GNVC +4%. IMAX +4%.
Losers: LXRX -10%. TTM -7%. IRE -6%. SSTI -6%. YRCW -4%. AIB -4%. PEIX -4%. Comment! -
Friday, March 5, 2010, 9:00 AM
Premarket gainers: ITMN +81%. AIB +13%. TIVO +8%. IRE +6%. CPBY +6%. GNVC +4%. AGT +4%.
Losers: GPRE -6%. CNXT -6%. NG -5%. OSG -4%. Comment! -
Wednesday, March 3, 2010, 9:10 AM
Premarket gainers: SWWC +52%. NOVL +28%. LSCC +12%. DAN +6%. HOV +5%. PUK +5%. CLDX +4%. ELN +4%. GNVC +4%. BCS +4%. JOYG +4%.
Losers: MDVN -68%. VISN -28%. CMED -7%. CPNO -5%. PAY -5%. NFLX -5%. Comment! -
Tuesday, February 16, 2010, 9:00 AM
Premarket gainers: TRA +22%. DSCO +19%. CPSL +16%. NIHD +12%. BCS +11%. APWR +8%. NVMI +6%. GNVC +5%. GNRC +4%. SNV +4%. UBS +4%. HL +4%. IOC +4%. ARTG +4%.
Losers: RIGL -8%. OTE -8%. PMI -5%. NBG -5%. CTIC -5%. STEC -4%. Comment! -
Wednesday, January 27, 2010, 9:10 AM
Premarket gainers: MNI +19%. ME +18%. SANM +16%. PXP +9%. BRK +8%. ROK +7%. KT +7%. GILD +6%. ALTR +5%. TEL +5%. GNVC +5%. F +4%. APC +4%. AAI +4%. UAUA +4%.
Premarket losers: TSFG -18%. HERO -11%. FSIN -5%. CAT -5%. CX -4%. Comment! -
Tuesday, January 26, 2010, 9:00 AM
Premarket gainers: VMW +16%. AMLN +16%. ALKS +14%. SHW +6%. TLAB +6%. ZION +5%. NVO +4%. SIRI +4%. BHI +4%. TRV +4%.
Losers: WFT -8%. FUN -6%. X -5%. GNVC -4%. ARCC -4%. Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.





